Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 Registry.

Huemer, F; Rinnerthaler, G; Jörg, B; Morre, P; Stegbuchner, B; Proksch, E; Fleimisch, S; Oberkofler, H; Kremser, I; Greil, R; Egle, A; Geroscience. 2021; 43(4):-1897

Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases

Kwik, M; Hainzl, S; Oppelt, J; Tichy, B; Koller, U; Bernardinelli, E; Steiner, M; Zara, G; Nofziger, C; Weis, S; Paulmichl, M; Dossena, S; Patsch, W; Soyal, SM; Int J Mol Sci. 2021; 22(7):

Preparing for future waves and pandemics: a global hospital survey on infection control measures and infection rates in COVID-19.

Matoori, S; Kuritzkes, DR; Goh, Y; Quek, ST; Wang, L; Sun, Z; di Marco, F; Borleri, D; Buoro, S; Fagiuoli, S; Ferrari, T; Rizzi, M; Raimondi, F; Cesa, S; Koh, DM; Froehlich, JM; Janssen, S; Lange, B; Egle, A; Erb, S; Mossdorf, E; Gutzeit, A; Antimicrob Resist Infect Control. 2021; 10(1): 170

The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8

Filipits, M; Rudas, M; Kainz, V; Singer, CF; Fitzal, F; Bago-Horvath, Z; Greil, R; Balic, M; Regitnig, P; Halper, S; Hulla, W; Egle, D; Barron, S; Loughman, T; OxxxLeary, D; Gallagher, WM; Hlauschek, D; Gnant, M; Dubsky, P CLIN CANCER RES. 2021; 27(21): 5931-5938.

Safety and efficacy of durvalumab with R-CHOP or R-2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

Nowakowski, GS; Willenbacher, W; Greil, R; Larsen, TS; Patel, K; Jager, U; Manges, RF; Trumper, L; Everaus, H; Kalakonda, N; Brown, P; Jorgensen, JM; Cunningham, D; DellxxxAringa, J; Fox, B; Rubio, ND; Kilavuz, N; Casadebaig, ML; Manzke, O; Munoz, J INT J HEMATOL. 2021;

ASCO 2021-an update on metastastic colorectal cancer

Weiss, L MEMO-MAG EUR MED ONC. 2021;

Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast Cancer

Balic, M; Rinnerthaler, G; Bartsch, R BREAST CARE. 2021;

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.

Aftimos, P; Oliveira, M; Irrthum, A; Fumagalli, D; Sotiriou, C; Gal-Yam, EN; Robson, ME; Ndozeng, J; Di Leo, A; Ciruelos, EM; de Azambuja, E; Viale, G; Scheepers, ED; Curigliano, G; Bliss, JM; Reis, JS; Colleoni, M; Balic, M; Cardoso, F; Albanell, J; Duhem, C; Marreaud, S; Romagnoli, D; Rojas, B; Gombos, A; Wildiers, H; Guerrero-Zotano, A; Hall, P; Bonetti, A; Larsson, KF; Degiorgis, M; Khodaverdi, S; Greil, R; Sverrisdottir, A; Paoli, M; Seyll, E; Loibl, S; Linderholm, B; Zoppoli, G; Davidson, NE; Johannsson, OT; Bedard, PL; Loi, S; Knox, S; Cameron, DA; Harbeck, N; Montoya, ML; Brandao, M; Vingiani, A; Caballero, C; Hilbers, FS; Yates, LR; Benelli, M; Venet, D; Piccart, MJ CANCER DISCOV. 2021; 11(11): 2796-2811.

Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma.

Leb-Reichl, VM; Kienzl, M; Kaufmann, A; Stoecklinger, A; Tockner, B; Kitzmueller, S; Zaborsky, N; Steiner, M; Brachtl, G; Trattner, L; Kreideweiss, P; Reinsch, C; Panzner, S; Greil, R; Strunk, D; Bauer, JW; Gratz, IK; Guttmann-Gruber, C; Hofbauer, JP J IMMUNOTHER CANCER. 2021; 9(10):

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).

Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Hubalek, M; Petru, E; Sandholzer, M; Andel, J; Balic, M; Melchardt, T; Hauser-Kronberger, C; Schmitt, CA; Ulmer, H; Greil, R; Ther Adv Med Oncol. 2021; 13: 17588359211042301